跳到主要內容

臺灣博碩士論文加值系統

(2600:1f28:365:80b0:8005:376a:2d98:48cd) 您好!臺灣時間:2025/01/18 08:51
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:陳緯傑
研究生(外文):Wei-Jie Chen
論文名稱:製備毛細免疫親和性管柱,以液相層析電噴灑質譜儀直接分離且定量檢測尿液中甲基安非他命、亞甲雙氧甲基安非他命和副甲氧基甲基安非他命之光學異構物
論文名稱(外文):Preparation of capillary immunoaffinity columns for direct separation and quantitation of the enantiomers of methamphetamine, methylenedioxymethamphetamine and paramethoxymethamphetamine in urine samples with liquid chromatography electrospray ionization-
指導教授:周璁瑩
學位類別:碩士
校院名稱:慈濟大學
系所名稱:醫學生物技術研究所
學門:醫藥衛生學門
學類:醫學技術及檢驗學類
論文種類:學術論文
畢業學年度:94
語文別:中文
論文頁數:43
中文關鍵詞:光學異構物副甲氧基甲基安非他命亞甲雙氧甲基安非他命甲基安非他命毛細免疫親和性管柱
外文關鍵詞:methylenedioxymethamphetamineparamethoxymethamphetaminemethamphetaminecapillary immunoaffinity columns
相關次數:
  • 被引用被引用:0
  • 點閱點閱:367
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
本研究用(S)-甲基安非他命老鼠單株抗體((S)-(+)-methamphetamine mouse monoclonal antibody )修飾矽膠,以之填充毛細管而成毛細免疫親和性管柱(capillary immunoaffinity columns; CIACs),兩支CIACs(規格為:內徑250 μm、外徑363 μm和長度13 cm)輪流交替使用,同時行萃取及偵測的工作。尿液樣品只需加MA-d14作內標(internal standard; IS),並經0.45 μm濾膜過濾,即注入檢測系統,移動相為醋酸鹽水溶液,檢測過程中不用有機溶劑,對操作人員健康和環境污染不造成任何傷害,此法在20分鐘內,直接分離且定量檢測尿液中甲基安非他命(methamphetamine;MA)、亞甲雙氧甲基安非他命 (methylenedioxymethamphetamine;MDMA)和副甲氧基甲基安非他命(paramethoxymethamphetamine;PMMA)等光學異構物。用50、250和500 ng/mL三種不同濃度尿液樣品,測其二次質譜,以各物種特徵碎片離子畫其萃取離子層析圖(extracted ion chromatogram; EIC),從各物種EIC圖中峰面積與IS的EIC峰面積之比值,得定量檢測上述五種成份之檢量線,此法在不同天檢測添加五種不同濃度之上述五種成份之尿液樣品五次,結果得知:最低偵測濃度 (limit of detection; LOD)和最低定量濃度(limit of quantitation; LOQ)分別介於7.7~11.9 ng/mL和25.6~39.5 ng/mL之間,相對標準偏差(relative standard deviation; RSD)及相對誤差(relative error; RE) 分別在25﹪及15﹪以下,結果顯示此法具高精密度(precision)和準確度(accuracy),可實際用於尿液中上述五種成分之檢測。
This study developed a method capable of direct quantitation of the enantiomers of methamphetamine (MA) , 3, 4-methylenedioxy methamphetamine (MDMA; ecstasy) and paramethoxymethamphetamine (PMMA) in urine samples by preparing capillary immunoaffinity columns (CIACs) and applying the CIACs to a liquid chromatography electrospray ionization-mass spectrometry system (LC/MS). Two CIACs were prepared by packing (S)-methamphetamine monoclonal mouse antibody immobilized silica into two capillary columns (I. D. 250 μm, O.D. 365 μm and length 13 cm), and these two CIACs were used for extracting analytes from urine samples and detecting the analytes by the LC/MS system alternatively. Aqueous ammonium acetate buffers were used as the mobile phase. Urine samples spiked with different concentrations of S(+)-MA , racemic MDMA and racemic PMMA were added with fixed concentration of racemic deuterated methamphetamine (MA-d14) as internal standard (IS), filtered through a membrane and injected into the LC/MS system without any further pre-treatment. Protonated molecular ion of MA (m/z 150), MDMA (m/z 194), PMMA (m/z 180) and MA-d14 (m/z 164) were isolated and further fragmented, the respective product ions, m/z 119 for MA, m/z 163 for MDMA, m/z 149 for PMMA and m/z 130 for MA-d14 were collected for quantitative determination. The results exhibited that, between-day, accuracy and precision (n = 5) of the method are fairly good.
第一章 前言 1
1-1研究背景 1
1-2 研究動機 1
1-3 研究範圍 1
1-4 研究所面對之困難與解決之道 2
第二章 文獻探討 3
2-1 MA、MDMA和PMMA光學異構物之藥理 3
2-2 安非他命類藥物之光學異構物分離 4
第三章 實驗部份 5
3-1 實驗材料 5
3-2製備填充材料 5
3-3製備毛細免疫親合性管柱 6
3-4製備樣品 6
3-5-1層析方法一 6
3-5-2層析方法二 7
3-6 MS之設定參數 7
第四章 結果與討論 8
4-1安非他命類藥物之選擇 8
4-2 CIAC鑑定AP、EPHEDRINE和MDA之光學異構物 8
4-3 CIAC鑑定HMMA 9
4-4 CIAC鑑定MDEA 9
4-5管柱內PH值變化 9
4-6 CIACS在PH7.0時對(S)-(+)-MA之最大吸附量 10
4-7 MA定性分析 10
4-8 利用IAC從甲醇中萃取 MDMA和PMMA之光學異構物並分離和收集 10
4-9 MDMA和PMMA之光學異構物的定性分析 11
4-10 (S)-(+)-MA、MDMA及PMMA之光學異構物和(R)-(-)-FENFLURAMINE之定量 11
4-11 (S)-(+)-MA、MDMA與PMMA之光學異構物和 R(-)-FENFLURAMINE之檢量線(CALIBRATION CURVES) 12
4-12 最低偵測濃度(LOD)及最低定量濃度(LOQ)的評估 12
4-13 準確度(ACCURACY)與精密度(PRECISION)的評估 12
4-14 CIACS壽命探討 13
4-15 線上萃取與離線萃取 13
第五章 結論 14
參考文獻 15
附錄 18
[1] E. Meyer, J.F. Van Bocxlaer, I.M. Dirinck, W.E. Lambert, L. Thienpont,A.P. De Leenheer. J. Anal. Toxicol. 21 (1997) 236.
[2] F.T. Peters, T. Kraemer, H.H. Maurer.Clin. Chem. 48 (9) (2002) 1472.
[3] H. Kalant. CMAJ. 165 (2001) 917.
[4] T. Kraemer and H.H. Maurer. Ther. Drug Monit. 24 (2002) 277.
[5]Baselt,R.C.,Cravey,R.H.Disposition of Toxic drugs and chemicals in man,forth edition ,chemical toxicology institute,foster city ,CA,USA (1995) 685.
[6] Athiwat Hutchaleelaha, Michael Mayersohnx.J. Pharm. Sci. 85 (1996) 541.
[7] Nieves Pizarro, Magı´ Farré, Mitona Pujadas, Ana Ma Peiró, Pere N Roset, Jesús Joglar, and Rafael de la Torre. Drug Metab. Dispos.32 (2004) 9.
[8] R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man. In Chemical Toxicology Institute, 5th ed. Biomedical Publications,Foster City, CA,(2000) 547.
[9] Sys Stybe Johansen,A. Carsten Hansen, Irene Breum Müller, Jytte Banner Lundemose,and Maria-B. Franzmann. J Anal Toxicol .27 (2003) 253.
[10] Ju¨rgen Becker, Peter Neis, Jo¨rg Ro¨hrich, Siegfried Zo¨rntlein. Leg Med. 5 (2003) 138.
[11] Heo YJ, Whang YS, In MK, Lee KJ. J Chromatogr B Biomed Sci Appl .741 (2000)221.
[12] Nieves Pizarro1, Jordi Ortuño1, Magí Farré1,2, Cándido Hernández-López1 etc. J Anal Toxicol. 26 (2002) 157.
[13] Louise Bang Rasmussen, Kristine Høje Olsen, Sys Stybe Johansen. J Chromatogr B. xxx (2006) xxx
[14] D. Hensley, J.T. Cody.J. Anal. Toxicol. 23 (1999) 518.
[15] Frank T. Peters, Thomas Kraemer, and Hans H. Maurer. Clin Chem. 48:9 (2002)1472
[16] Osama Al-Dirbashi, Mitsuhiro Wada, Naotaka Kuroda, Shigeko Inuduka2 and Kenichiro Nakashima1. Biomed. Chromatogr. 13 (1999) 543.
[17] Ahai C. Lua, Tsong-Yung Chou. J Chromatogr A. 967 (2002) 191
[18] Ahai C. Lua, Yenny Sutono, Tsong-Yung Chou. Anal. Chim. Acta xxx (2006) xxx
[19] R. Mertens, M. Stu¨ ning, E.W. Weiler.Naturwissenschaften 69 (1982) 595.
[20] J.P. Knox, G. Galfre. Anal. Biochem. 155 (1986) 92.
[21] A. Kussak, B. Andersson, K. Andersson.J. Chromatogr. B.656 (1994) 329
[22] Christian G. Huber, Alexander Krajete. J Chromatogr A. 870 (2000) 413.
[23] Stefan Bieri, Emmanuel Varesio, Orlando Mu˜noz ,Jean-Luc Veuthey, Philippe Christen. J Pharm Biomed Anal. 40 (2006) 545
[24] Dae Young Bang, Dukjin Kang, Myeong Hee Moon. J Chromatogr A. 1104 (2006) 222
[25] J.K. Fallon, A.T. Kicman, J.A. Henry, P.J. Milligan, D.A. Cowan, A.J.Hutt. Clin. Chem. 45 (1999) 1058.
[26] Liliane Ferreira Martins , Michel Yegles , Heesun Chung, Robert Wennig . J Chromatogr B. xxx (2006) xxx.
[27] Satoshi Chinaka , Seishi Tanaka, Nariaki Takayama, Kiyonobu Komai,Tohru Ohshima , Kazumasa Ueda.J Chromatogr B. 749 (2000) 111.
[28] M. HIRAMATSU, I" T. NABESHIMA, T. KAMEYAMA, Y. MAEDA AND A. K. CHOt I. Pharmacol. Biochem. Behav.33(1989) 343.
[29] R.L. FITZGERALD. J Chromatogr. 490 (1989) 59.
[30] Yukiko Makino, Ayako Suzuki, Takashi Ogawab, Osamu Shirota. J Chromatogr B. 729 (1999) 97
[31] M. Katagi, H. Nishioka, K. Nakajima, H. Tsuchihashi, H. Fujima, H. Wada,K. Nakamura K. Makino. J Chromatogr B.676 (1996) 35.
[32] John T. Cody. J Chromatogr. 580 (1992) 77.
[33] J.T. Cody.J. Anal. Toxicol. 14 (1990) 321.
[34] A. Poklis, R.L. Fitzgerald, K.V. Hall, J.-J. Saady.Forensic Sci. Int. 59 (1993) 63.
[35] Terry M. Phillips. Anal. Chim. Acta. 372 (1998) 209
[36] Li-Tzy Wu a, William E. Schlenger , Deborah M. Galvin. Drug Alcohol Depend 84 (2006) 102
[37] Tamanna Sultana, Mitchell E. Johnson. J Chromatogr A. 1101 (2006) 278
[38] IIIKARU SAJI. KIYOSHI TANAKA and NORIAKI KONDO. Plant Sci. 69 (1990) 1
[39]劉涓等.專利公報. 公告號:288020.中華民國八十五年 12
電子全文 電子全文(本篇電子全文限研究生所屬學校校內系統及IP範圍內開放)
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊